Combination of intensive chemotherapy and imatinib (IDEAMOP regimen) for the treatment of newly diagnosed BCR-ABL positive acute lymphoblastic leukemia; Excellent efficacy without increasing toxicity.

被引：0
|
作者：
Yanada, M
Emi, N
Usui, N
Takeuchi, J
Sugiura, I
Takeuchi, M
Kobayashi, T
Yagasaki, F
Ohtake, S
Matsuo, K
Naoe, T
Ohno, R
机构：
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2736
引用
收藏
页码：748A / 748A
页数：1
相关论文
共 50 条
  • [1] Imatinib in combination with chemotherapy for newly diagnosed BCR/ABL-positive acute lymphoblastic leukemia in adults
    Ohno, R.
    Yanada, M.
    Naoe, T.
    ANNALS OF HEMATOLOGY, 2006, 85 : 84 - 86
  • [2] Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
    Pfeifer, H.
    Lange, T.
    Wystub, S.
    Wassmann, B.
    Maier, J.
    Binckebanck, A.
    Giagounidis, A.
    Stelljes, M.
    Schmalzing, M.
    Duehrsen, U.
    Wunderle, L.
    Serve, H.
    Brueck, P.
    Schmidt, A.
    Hoelzer, D.
    Ottmann, O. G.
    LEUKEMIA, 2012, 26 (07) : 1475 - 1481
  • [3] Serial Analysis of BCR-ABL Kinase Domain Mutations Prior to and During Imatinib Treatment for Newly Diagnosed and Recurrent BCR-ABL Positive Acute Lymphoblastic Leukemia.
    Pfeifer, Heike
    Wystub, Sylvia
    Wassmann, Barbara
    Maier, Jaqueline
    Lange, Thoralf
    Hochhaus, Andreas
    Hoelzer, Dieter
    Ottmann, Oliver
    BLOOD, 2009, 114 (22) : 806 - 806
  • [4] Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
    H Pfeifer
    T Lange
    S Wystub
    B Wassmann
    J Maier
    A Binckebanck
    A Giagounidis
    M Stelljes
    M Schmalzing
    U Dührsen
    L Wunderle
    H Serve
    P Brück
    A Schmidt
    D Hoelzer
    O G Ottmann
    Leukemia, 2012, 26 : 1475 - 1481
  • [5] High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia
    Yanada, M
    Takeuchi, J
    Sugiura, I
    Akiyama, H
    Usui, N
    Yagasaki, F
    Emi, N
    Miyazaki, Y
    Ohtake, S
    Jinnai, I
    Matsuo, K
    Naoe, T
    Ohno, R
    BLOOD, 2005, 106 (11) : 520A - 520A
  • [6] Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia
    Fujisawa, Shin
    Mizuta, Shuichi
    Akiyama, Hideki
    Ueda, Yasunori
    Aoyama, Yasutaka
    Hatta, Yoshihiro
    Kakihana, Kazuhiko
    Dobashi, Nobuaki
    Sugiura, Isamu
    Onishi, Yasushi
    Maeda, Tomoya
    Imai, Kiyotoshi
    Ohtake, Shigeki
    Miyazaki, Yasushi
    Ohnishi, Kazunori
    Matsuo, Keitaro
    Naoe, Tomoki
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 367 - 374
  • [7] INCREASING BCR-ABL EXPRESSION LEVELS AND/OR OCCURRENCE OF ABL POINT MUTATIONS NOT ALWAYS PREDICT RESISTANCE TO IMATINIB MESYLATE IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Grammatico, S.
    Elia, L.
    Vitale, A.
    Matarazzo, M.
    Falciani, V
    Rago, A.
    Cenfra, N.
    Peluso, A. L.
    Pedace, L.
    Grammatico, P.
    Pane, F.
    Meloni, G.
    Foa, R.
    Cimino, G.
    HAEMATOLOGICA, 2008, 93 : S88 - S89
  • [8] Treatment of elderly patients with acute lymphoblastic leukemia - Evidence for a benefit of imatinib in BCR-ABL positive patients
    Brandwein, JM
    Gupta, V
    Wells, RA
    Schuh, AC
    Schimmer, AD
    Lipton, JH
    Messner, HA
    Yi, QL
    Chun, K
    Kamel-Reid, S
    Minden, MD
    LEUKEMIA RESEARCH, 2005, 29 (12) : 1381 - 1386
  • [9] Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia
    Towatari, M
    Yanada, M
    Usui, N
    Takauchi, J
    Sugiura, I
    Takeuchi, M
    Yagasaki, F
    Kawai, Y
    Miyawaki, S
    Ohtake, S
    Jinnai, I
    Matsuo, K
    Naoe, T
    Ohno, R
    BLOOD, 2004, 104 (12) : 3507 - 3512
  • [10] Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lee, KH
    Lee, JH
    Choi, SJ
    Lee, JH
    Seol, M
    Lee, YS
    Kim, WK
    Lee, JS
    Seo, EJ
    Jang, S
    Park, CJ
    Chi, HS
    LEUKEMIA, 2005, 19 (09) : 1509 - 1516
12345